Alvotech (ALVO) Accounts Payables (2020 - 2026)
Alvotech's (ALVO) quarterly Accounts Payables came in at $97.9 million in Q1 2026, up 44.16% YoY from $67.9 million in Q1 2025, and down 22.41% on a QoQ basis from $126.1 million in Q4 2025.
Alvotech (ALVO) Accounts Payables (2020 - 2026) Analysis & Trends
Alvotech (ALVO) has 7 years of Accounts Payables data on file, last reported at $97.9 million in Q1 2026.
- Quarterly Accounts Payables rose 44.16% year-over-year to $97.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $97.9 million (up 44.16% YoY) and the FY2025 annual result came in at $126.1 million, up 87.89% from the prior year.
- Accounts Payables eased to $97.9 million in Q1 2026, from $126.1 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $126.1 million in Q4 2025 to a low of $29.8 million in Q1 2023.
- A 5-year average of $67.8 million and a median of $62.8 million in 2024 frame the typical range for Accounts Payables.
- Annual changes were most pronounced in 2024 — Accounts Payables dropped 16.68% — and 2025, when it surged 87.89%.
- Tracing ALVO's Accounts Payables over 5 years: stood at $49.2 million in 2022, then soared by 63.79% to $80.6 million in 2023, then retreated by 16.68% to $67.1 million in 2024, then surged by 87.89% to $126.1 million in 2025, then decreased by 22.41% to $97.9 million in 2026.
- The last three Accounts Payables figures came in at $97.9 million (Q1 2026), $126.1 million (Q4 2025), and $91.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 356.00 Mn |
| 10 | Alvotech | 1.26 Bn | 1.26 Bn | 5.09 Mn | 97.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 97.87 Mn |
| Dec 31, 2025 | 126.12 Mn |
| Sep 30, 2025 | 91.63 Mn |
| Jun 30, 2025 | 84.28 Mn |
| Mar 31, 2025 | 67.89 Mn |
| Dec 31, 2024 | 67.13 Mn |
| Sep 30, 2024 | 57.72 Mn |
| Jun 30, 2024 | 58.57 Mn |
| Mar 31, 2024 | 50.18 Mn |
| Dec 31, 2023 | 80.56 Mn |
| Jun 30, 2023 | 43.93 Mn |
| Mar 31, 2023 | 29.77 Mn |
| Dec 31, 2022 | 49.19 Mn |
| Jun 30, 2022 | 44.73 Mn |
| Dec 31, 2021 | 28.59 Mn |
| Dec 31, 2020 | 11.96 Mn |